Listen "ACC/AHA Coronary Revascularization Guidelines (Segment 1)"
Episode Synopsis
A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with 3-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG vs medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.
More episodes of the podcast The Cardiac Exchange
Left Atrial Appendage Management (Segment 3)
26/02/2024
Left Atrial Appendage Management (Segment 2)
26/02/2024
Left Atrial Appendage Management (Segment 1)
26/02/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.